Cardinal Health, Inc. (CAH) To Go Ex-Dividend on January 2nd

Cardinal Health, Inc. (NYSE:CAH) announced a quarterly dividend on Tuesday, November 4th. Investors of record on Friday, January 2nd will be given a dividend of 0.5107 per share on Thursday, January 15th. This represents a c) dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd.

Cardinal Health has increased its dividend payment by an average of 0.0%per year over the last three years and has increased its dividend annually for the last 29 consecutive years. Cardinal Health has a dividend payout ratio of 22.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Cardinal Health to earn $8.95 per share next year, which means the company should continue to be able to cover its $2.04 annual dividend with an expected future payout ratio of 22.8%.

Cardinal Health Stock Performance

Shares of NYSE CAH traded up $0.53 during midday trading on Wednesday, hitting $207.74. 80,419 shares of the company’s stock traded hands, compared to its average volume of 2,393,639. The stock has a market capitalization of $49.36 billion, a price-to-earnings ratio of 31.33, a price-to-earnings-growth ratio of 1.51 and a beta of 0.63. The firm has a fifty day moving average of $198.26 and a 200 day moving average of $170.92. Cardinal Health has a 1 year low of $117.53 and a 1 year high of $214.93.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the previous year, the business posted $1.88 earnings per share. The firm’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CAH shares. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Argus upped their price target on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. TD Cowen raised their price objective on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 3rd. Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a research note on Friday, October 31st. Finally, Wells Fargo & Company increased their price target on Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $209.00.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.